Deep Track Capital, LP - Sep 30, 2025 SCHEDULE 13G/A Report for Tarsus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TARS)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Tarsus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
TARS
Shares outstanding
42.2M shares
Disclosed Ownership
3M shares
Ownership
7.11%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 08:23 AM
Date of event
Sep 30, 2025
Previous filing
Jul 28, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 7.11% 3M 0 3M /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 7.11% 3M 0 3M /s/ David Kroin David Kroin, Director
David Kroin 7.11% 3M 0 3M /s/ David Kroin David Kroin